{
  "label": "clinical_signal_03_dx_renal_biomarker_study_030",
  "artifact_type": "distractor_episode",
  "artifact_id": "sha256:8133ec92953f6b88f0486497db7231a770955aac0196db7c138830015142ad92",
  "input_ids": [
    "sha256:b4ba5337b06c8de68ac3315db1a4f6980c5bd48efd529c3914f30297d6afd329",
    "sha256:c334c83f0e5586d31926bcb6e60115e9bfeccda6fed885884ee61b742c0bfe26"
  ],
  "prompt_id": null,
  "model_config": null,
  "created_at": "2026-02-17T11:58:16.403582",
  "content": "## 2024-09-23 Daily Operations Summary\n\n### Enrollment\n- Total Enrolled: 87\n- Active: 74\n- Screen Failures Cumulative: 61\n- Withdrawals Cumulative: 13\n\n#### By Cohort\n- 10mg: 20\n- 25mg: 21\n- 50mg: 23\n- 100mg: 23\n\n### Biomarkers By Cohort\n#### 10mg\n- KIM-1 (ng/mL) Mean: 1.81\n- KIM-1 (ng/mL) SD: 0.49\n- NGAL (ng/mL) Mean: 41.7\n- NGAL (ng/mL) SD: 13.9\n- Cystatin C (mg/L) Mean: 0.91\n- Cystatin C (mg/L) SD: 0.11\n- eGFR (mL/min) Mean: 78.3\n- eGFR (mL/min) SD: 12.4\n- UACR (mg/g) Mean: 51.6\n- UACR (mg/g) SD: 19.2\n- Serum Creatinine (mg/dL) Mean: 1.19\n- Serum Creatinine (mg/dL) SD: 0.11\n- Urine Protein (mg/dL) Mean: 30.4\n- Urine Protein (mg/dL) SD: 8.9\n- Urine Output (mL/24h) Mean: 1946\n- Urine Output (mL/24h) SD: 323\n\n#### 25mg\n- KIM-1 (ng/mL) Mean: 0.9\n- KIM-1 (ng/mL) SD: 0.2\n- NGAL (ng/mL) Mean: 93.0\n- NGAL (ng/mL) SD: 12.1\n- Cystatin C (mg/L) Mean: 0.8\n- Cystatin C (mg/L) SD: 0.11\n- eGFR (mL/min) Mean: 65.3\n- eGFR (mL/min) SD: 11.9\n- UACR (mg/g) Mean: 122.1\n- UACR (mg/g) SD: 10.2\n- Serum Creatinine (mg/dL) Mean: 1.2\n- Serum Creatinine (mg/dL) SD: 0.28\n- Urine Protein (mg/dL) Mean: 15.7\n- Urine Protein (mg/dL) SD: 3.3\n- Urine Output (mL/24h) Mean: 1599\n- Urine Output (mL/24h) SD: 355\n\n#### 50mg\n- KIM-1 (ng/mL) Mean: 2.47\n- KIM-1 (ng/mL) SD: 0.47\n- NGAL (ng/mL) Mean: 94.0\n- NGAL (ng/mL) SD: 10.3\n- Cystatin C (mg/L) Mean: 1.01\n- Cystatin C (mg/L) SD: 0.15\n- eGFR (mL/min) Mean: 71.6\n- eGFR (mL/min) SD: 14.5\n- UACR (mg/g) Mean: 58.7\n- UACR (mg/g) SD: 11.8\n- Serum Creatinine (mg/dL) Mean: 1.16\n- Serum Creatinine (mg/dL) SD: 0.1\n- Urine Protein (mg/dL) Mean: 39.0\n- Urine Protein (mg/dL) SD: 6.2\n- Urine Output (mL/24h) Mean: 1958\n- Urine Output (mL/24h) SD: 369\n\n#### 100mg\n- KIM-1 (ng/mL) Mean: 1.31\n- KIM-1 (ng/mL) SD: 0.34\n- NGAL (ng/mL) Mean: 57.5\n- NGAL (ng/mL) SD: 11.4\n- Cystatin C (mg/L) Mean: 0.88\n- Cystatin C (mg/L) SD: 0.13\n- eGFR (mL/min) Mean: 73.9\n- eGFR (mL/min) SD: 13.9\n- UACR (mg/g) Mean: 120.4\n- UACR (mg/g) SD: 15.3\n- Serum Creatinine (mg/dL) Mean: 1.2\n- Serum Creatinine (mg/dL) SD: 0.13\n- Urine Protein (mg/dL) Mean: 24.0\n- Urine Protein (mg/dL) SD: 6.2\n- Urine Output (mL/24h) Mean: 2010\n- Urine Output (mL/24h) SD: 363\n\n### Dose Response\n- KIM-1 Dose Correlation (r): 0.634\n- NGAL Dose Correlation (r): 0.386\n- eGFR Dose Correlation (r): -0.488\n- UACR Dose Correlation (r): 0.364\n\n### Safety Labs\n- Hemoglobin (g/dL) Mean: 13.2\n- Hemoglobin (g/dL) SD: 1.5\n- Hematocrit (%) Mean: 41.4\n- Hematocrit (%) SD: 2.4\n- WBC (K/\u00b5L) Mean: 7.6\n- WBC (K/\u00b5L) SD: 1.0\n- Platelets (K/\u00b5L) Mean: 218\n- Platelets (K/\u00b5L) SD: 48\n- Sodium (mEq/L) Mean: 139.7\n- Sodium (mEq/L) SD: 2.7\n- Potassium (mEq/L) Mean: 4.4\n- Potassium (mEq/L) SD: 0.4\n- Bicarbonate (mEq/L) Mean: 26.3\n- Bicarbonate (mEq/L) SD: 2.1\n- Phosphorus (mg/dL) Mean: 3.2\n- Phosphorus (mg/dL) SD: 0.4\n\n### Adverse Events\n- AE ID: RB-AE-3030, Description: dizziness, Grade: 1, Relatedness: not related, Resolved: false, Cohort: 25mg\n- AE ID: RB-AE-3061, Description: hyperkalemia, Grade: 2, Relatedness: not related, Resolved: true, Cohort: 10mg\n\n### Protocol Deviations\n- PD ID: RB-PD-3022, Description: Urine sample collection outside 24h window, Severity: moderate\n- PD ID: RB-PD-3033, Description: Blood pressure measurement not recorded at visit, Severity: minor\n\n### Events\n- Renal ultrasound images uploaded to central imaging core\n- Protocol training refresher completed for site coordinators\n- Lab kit resupply dispatched to sites with low inventory\n\n### Notes\n- Week 30: Renal biomarker collection on schedule. 87 subjects enrolled across 4 cohorts. eGFR and urinary biomarkers within expected variability.",
  "metadata": {
    "episode_type": "distractor",
    "theme": "renal_biomarker_study",
    "theme_index": 0,
    "local_index": 30,
    "scope_id": "clinical_signal_03",
    "layer_name": "distractor_episodes",
    "layer_level": 2,
    "build_fingerprint": {
      "scheme": "synix:build:v1",
      "digest": "b39286bd69ab4fc400a914137914eaa7bda71068fc11fdf31fc1054c8fc775f5",
      "components": {
        "transform": "a88665a5359d5ac5d2c858c77a2a19318c209adeea6fae2b838d79e11f6aba2b",
        "inputs": "e1e99cb871eaf7b9"
      }
    },
    "transform_fingerprint": {
      "scheme": "synix:transform:v2",
      "digest": "a88665a5359d5ac5d2c858c77a2a19318c209adeea6fae2b838d79e11f6aba2b",
      "components": {
        "transform_id": "01137a4997b78f86",
        "source": "c42d9c6282d5331f",
        "model": "1e2ccf75e96d7ee7"
      }
    }
  }
}